Document is current
Any future updates will be listed below
-
Authors
Bergqvist, Markus https://orcid.org/0009-0003-5716-3716
Park, Kyong-Su https://orcid.org/0000-0003-0902-7800
Karimi, Nasibeh https://orcid.org/0000-0003-1499-6876
Yu, Lijuan https://orcid.org/0000-0003-3558-3800
Lässer, Cecilia https://orcid.org/0000-0003-1279-1746
Lötvall, Jan https://orcid.org/0000-0001-9195-9249
-
Funding
Funding for this research was provided by:
Hjärt-Lungfonden (244018078)
Vetenskapsrådet (254018063)
University of Gothenburg
- License Information
-
More Information
Article History
Received: 10 October 2024
Accepted: 14 January 2025
First Online: 30 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: MB, KSP, CL and JL have equity in Exocure Sweden AB, developing EVs for therapeutic purposes. JL consults for ExoCoBio INC (South Korea).
